ESR1 and endometrial polyp: In addition, by comparing the combined expression of ER/PR, the risk of malignancy in the polyps was observed to be significantly higher when the expression of the two receptors was negative (ER−/PR−) in the stroma of the endometrial polyps (odds ratio, 6.5; 95% confidence interval, 2.05–20.29).